Capell WH and RH Eckel. 2005. Severe hypertriglyceridemia with history of treatment failure. Nat Clin Pract Endo Metab 1: 53-8.
Capell WH and RH Eckel. 2006. Treatment of hypertriglyceridemia. Curr Diab Reports
Capell, WH and RH Eckel. 2006. Treatment of hypertiglyceridemia. Curr Diab Rep 6: 230-40.
Hernandez, TL, WH Capell, P Wolfe, LA Gerard, and RH Eckel. 2006. Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus. Am J Card 98:1656-9.
Linnebur, SA, WH Capell, JJ Saseen, P Wolfe, and RH Eckel. 2007. Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations. J Clin Lipidol 1: 626-33.
Hernandez, TL, JP Sutherland, P Wolfe, M Allian-Sauer, WH Capell, ND Talley, HR Wyatt, G Foster, JO Hill, and RH Eckel. 2010. Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet. Am J Clin Nutr 91: 1-8.
Capell, WH, IR Schlaepfer, P Wolfe, PA Watson, DH Bessesen, MJ Pagliassotti, and RH Eckel. 2010. Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase. Am J Physiol Endo Metab 299: E576-83.
Lakin, A and W Capell. 2013. Biorepositories: Regulatory aspects of biospecimen collection. In: McManus, L and R Mitchell (Eds.), Atlas of Human Pathology. Online Publication: Elsevier, Inc.
Abernethy AP, Capell WH, Aziz NM, Ritchie C, Prince-Paul M, Bennett RE, Kutner JS. Ethical conduct of palliative care research: enhancing communication between investigators and institutional review boards. J Pain Symptom Manage. 2014 Dec;48(6):1211-21. PubMed PMID: 24879998
Abernethy AP, Capell WH, Aziz NM, Ritchie C, Prince-Paul M, Bennett RE, Kutner JS. Ethical conduct of palliative care research: enhancing communication between investigators and institutional review boards. J Pain Symptom Manage. 2014 Dec;48(6):1211-21. PubMed PMID: 24879998
Capell, WH, MP Bonaca, MR Nehler, E Chen, JM Kittelson, SS Anand, SD Berkowitz, ES Debus, F Fanelli, L Haskell, MR Patel, R Bauersachs, and WR. Hiatt. 2018. Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD). Am Heart J 199: 83-91.
Hess, CN, L Norgren, GM Ansel, WH Capell, JP Fletcher, FGR Fowkes, A Gottsäter, K Hitos, MR Jaff, J Nordanstig, and WR Hiatt. A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease with a Focus on Revascularization: A TASC Initiative. 2017. Circ 135: 2534-55.
Daddato, A, HL Wald, C Horney, DL Fairclough, EC Leister, M Coors, WH Capell, and RS Boxer. 2017. A randomized trial of heart failure disease management in skilled nursing facilities (SNF Connect): Lessons learned. Clin Trials 14: 308-13.
Capell WH, Bonaca MP, Nehler MR, Chen E, Kittelson JM, Anand SS, Berkowitz SD, Debus ES, Fanelli F, Haskell L, Patel MR, Bauersachs R, Hiatt WR. Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD). Am Heart J. 2018 May;199:83-91. PubMed PMID: 29754671